|
Latest News: The conference will also include a unique insight into the recent high-profile counterfeit drugs case in the UK, which was successfully resolved with the help of Pfizer and the MHRA. Also, we will get an insight into packaging small orders efficiently from Eli Lilly.
Industry dangers including the constant threat of counterfeit packaging and labelling, and the waves of new business regulations that are changing across Europe are having huge implications to pharmaceutical packaging and labelling strategies. Ensuring drug safety across the supply chain, understanding and complying with the latest regulatory standards for drug labelling, and keeping current on the newest and most pioneering packaging methods technology are just a taste of the issues that will be tackled at SMi’s 4th Pharmaceutical Packaging and Labelling Conference. SMi’s 4th Pharmaceutical Packaging and Labelling Innovations Conference is the place to be if you want to keep up-to-date with the latest industry developments and network with an international audience of fellow pharmaceutical packaging and labelling professionals. 6 Key Benefits of Attending 1. DISCOVER new practical approaches to anti-counterfeiting methods and authentication techniques
2. UNDERSTAND current and future regulatory issues within the pharmaceutical packaging and labelling industry (MHRA)
3. LEARN how to tackle the new ICH Q9 Quality Risk Management Guideline
4. DEVELOP the best cost-effective methods of the production process
5. INVESTIGATE different strategies of improving supply chain security
6. NETWORK with an array of experts in the packaging and labelling industry Hear contributions from leading industry experts, including: - Dr Anders Lofgren, Executive Product Design, AstraZeneca
- Jonathon Rucker, Director of Manufacturing, Eli Lilly
- Ingo Kaemmer, Head of Purchasing and Packaging Materials, Sandoz
- Max Vetter, Manager, ICC Counterfeiting Intelligence Bureau
- Ralph Dillon, Managing Director, Chicago Office, Compliance Surety Associates
- Danny Lee-Frost, Head, Enforcement, Medicines Healthcare products Regulatory Agency (MHRA)
- Dr John Gill, Senior Scientist, Royal National Institute for the Blind (RNIB)
- Stephen Wilkins, Chief Executive, Child Safety Packaging Group
- Dr Andreas Franken, Clinical Research / eSubmission, BAH
- Dr Klaus Menges, Head, Institute of Medicine Product and Strategy, Bfarm
- Marc Sluijs, EMEA Business Development Director Life Sciences, Oracle
- Professor David Cousins, Head of Safe Medication Practice, National Patient Safety Agency
This event is aimed at those with the following job titles: • Director of Packaging
• Director of Labelling
• Director of Quality Control
• Head of Manufacturing
• Director of Supply Chain
• Head of Logistics
• Head of Security
• Director of Operations
• Quality Assurance Director
• Director of Packaging and Labelling Design
• Director of Regulations
• Head of Compliance Previous attendees were from the following companies: - Wyeth
- GlaxoSmithKline
- Teva
- Sanofi-Aventis
- Sandoz
- Pfizer
- Novartis
- AstraZeneca
- Cardinal Health
- Alpharma
- Allergan
- MHRA
- Penn Pharmaceuticals
- BAH
- Bfarm
- Ipsen
- Hewlett Packard
- Domino UK
- Brecon Pharmaceuticals
- Schreiner Group
- Chrion Corp.
- GS1 UK
- Pharmion
- RNIB
- Zebra Technologies
- ABPI
- Americansource Bergen
- Alpvision
- Handicap Zero
- Jerini AG
|
Events Home Page
